Cargando…

Modulation of NKG2D Expression in Human CD8(+) T Cells Corresponding with Tuberculosis Drug Cure

BACKGROUND: Biomarkers predicting tuberculosis treatment response and cure would facilitate drug development. This study investigated expression patterns of the co-stimulation molecule NKG2D in human tuberculosis and treatment to determine its potential usefulness as a host biomarker of tuberculosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hassan, Syeda S., Cho, Jang-Eun, Akram, Muhammad, Fielding, Katherine L., Dockrell, Hazel M., Cliff, Jacqueline M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724721/ https://www.ncbi.nlm.nih.gov/pubmed/23922903 http://dx.doi.org/10.1371/journal.pone.0070063

Ejemplares similares

PD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis Treatment
por: Hassan, Syeda S., et al.
Publicado: (2015)

Excessive Cytolytic Responses Predict Tuberculosis Relapse After Apparently Successful Treatment
por: Cliff, Jacqueline M., et al.
Publicado: (2016)

CCL2 Responses to Mycobacterium tuberculosis Are Associated with Disease Severity in Tuberculosis
por: Hasan, Zahra, et al.
Publicado: (2009)

NKG7 Enhances CD8+ T Cell Synapse Efficiency to Limit Inflammation
por: Lelliott, Emily J., et al.
Publicado: (2022)

Targeting NKG2DL with Bispecific NKG2D–CD16 and NKG2D–CD3 Fusion Proteins on Triple–Negative Breast Cancer
por: Kaidun, Polina, et al.
Publicado: (2023)

CD8(+) T cells maintain killing of MHC-I-negative tumor cells through the NKG2D–NKG2DL axis
por: Lerner, Emily C., et al.
Publicado: (2023)

Soluble NKG2D ligands impair CD8(+) T cell antitumor function dependent of NKG2D downregulation in neuroblastoma
por: Zhang, Yi, et al.
Publicado: (2023)

NKG2D(+) IFN-γ(+) CD8(+) T Cells Are Responsible for Palladium Allergy
por: Kawano, Mitsuko, et al.
Publicado: (2014)

NKG2D signaling certifies effector CD8 T cells for memory formation
por: Perez, Cynthia, et al.
Publicado: (2019)

Functional Dichotomy between NKG2D and CD28-Mediated Co-Stimulation in Human CD8(+) T Cells
por: Rajasekaran, Kamalakannan, et al.
Publicado: (2010)

Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
por: Dockrell, Hazel M., et al.
Publicado: (2022)

CD8(+) T Cells Form the Predominant Subset of NKG2A(+) Cells in Human Lung Cancer
por: Chen, Yongyuan, et al.
Publicado: (2020)

NKG2D defines tumor‐reacting effector CD8(+) T cells within tumor microenvironment
por: Mojic, Marija, et al.
Publicado: (2021)

NKG2D(+)CD4(+) T Cells Kill Regulatory T Cells in a NKG2D-NKG2D Ligand- Dependent Manner in Systemic Lupus Erythematosus
por: Yang, Di, et al.
Publicado: (2017)

Can what have we learnt about BCG vaccination in the last 20 years help us to design a better tuberculosis vaccine?
por: Dockrell, Hazel M., et al.
Publicado: (2022)

NKG2D promotes CD8 T cell-mediated cytotoxicity and is associated with treatment failure in human cutaneous leishmaniasis
por: Sacramento, Laís A., et al.
Publicado: (2023)

Role of NKG2a/c(+)CD8(+) T cells in pathogenic versus non-pathogenic SIV infections
por: Huot, Nicolas, et al.
Publicado: (2021)

Differential expression of inhibitory receptor NKG2A distinguishes disease‐specific exhausted CD8(+) T cells
por: Chen, Xiangyu, et al.
Publicado: (2022)

Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer
por: Ducoin, Kathleen, et al.
Publicado: (2022)

TCF-1 regulates NKG2D expression on CD8 T cells during anti-tumor responses
por: Harris, Rebecca, et al.
Publicado: (2022)

CD8(+)T cell–specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8(+)T cell accumulation in tumors
por: Hu, Jiemiao, et al.
Publicado: (2014)

Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas
por: Hagelstein, Ilona, et al.
Publicado: (2021)

NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division
por: Borst, Linda, et al.
Publicado: (2021)

Between Innate and Adaptive Immune Responses: NKG2A, NKG2C, and CD8(+) T Cell Recognition of HLA-E Restricted Self-Peptides Acquired in the Absence of HLA-Ia
por: Pump, Wiebke C., et al.
Publicado: (2019)

Emergence of human CMV-induced NKG2C(+) NK cells is associated with CD8(+) T-cell recovery after allogeneic HCT
por: van der Ploeg, Kattria, et al.
Publicado: (2023)

Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia
por: Märklin, Melanie, et al.
Publicado: (2019)

CD8(+) T cells in HIV control, cure and prevention
por: Collins, David R., et al.
Publicado: (2020)

Control of spontaneous ovarian tumors by CD8+ T cells through NKG2D-targeted delivery of antigenic peptide
por: Kang, Tae Heung, et al.
Publicado: (2013)

CD8+ T lymphocytes are sensitive to NKG2A/HLA-E licensing interaction: role in the survival of cancer patients
por: Gimeno, Lourdes, et al.
Publicado: (2021)

NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence
por: Heath, John, et al.
Publicado: (2016)

Recognition of the Class Ib Molecule Qa-1(b) by Putative Activating Receptors Cd94/Nkg2c and Cd94/Nkg2e on Mouse Natural Killer Cells
por: Vance, Russell E., et al.
Publicado: (1999)

The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer
por: Tan, Ge, et al.
Publicado: (2023)

Circulating NKG2A–NKG2D+ CD56dimCD16+ Natural Killer (NK) Cells as Mediators of Functional Immunosurveillance in Kidney Transplant Recipients
por: Zhu, Li, et al.
Publicado: (2020)

Foreign Correspondence: Chronic Otorrhœa and Its Cure by Alcohol
por: Calhoun, A. W.
Publicado: (1872)

Murine T-Lymphomas Corresponding to the Immature CD4(-)8(+) Thymocyte Subset
por: Richie, Ellen R., et al.
Publicado: (1991)

Engagement of NKG2D on Bystander Memory CD8 T Cells Promotes Increased Immunopathology following Leishmania major Infection
por: Crosby, Erika J., et al.
Publicado: (2014)

Oncolytic measles virus enhances antitumour responses of adoptive CD8(+)NKG2D(+) cells in hepatocellular carcinoma treatment
por: Chen, Aiping, et al.
Publicado: (2017)

Stress Signal ULBP4, an NKG2D Ligand, Is Upregulated in Multiple Sclerosis and Shapes CD8(+) T-Cell Behaviors
por: Carmena Moratalla, Ana, et al.
Publicado: (2021)

New prospects on the NKG2D/NKG2DL system for oncology
por: Ullrich, Evelyn, et al.
Publicado: (2013)

Fusion Proteins of NKG2D/NKG2DL in Cancer Immunotherapy
por: Ding, Hui, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7s1h0qua23v4rhq90mv13q3lqf